z-logo
open-access-imgOpen Access
Will the epidemic of metabolic syndrome raise the prevalence of antiplatelet drug resistance?
Author(s) -
Richard Kones,
Umme Rumana
Publication year - 2013
Publication title -
international journal of applied and basic medical research/international journal of applied and basic medical research
Language(s) - English
Resource type - Journals
eISSN - 2248-9606
pISSN - 2229-516X
DOI - 10.4103/2229-516x.117047
Subject(s) - medicine , aspirin , antiplatelet drug , antithrombotic , thromboxane a2 , acute coronary syndrome , stroke (engine) , clopidogrel , platelet , cardiology , pharmacology , intensive care medicine , myocardial infarction , mechanical engineering , engineering

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here